Publicaciones en colaboración con investigadoras/es de Hospital Universitario de Donostia (17)

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

2015

  1. Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 4, pp. 263-273

  2. Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

    World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174

  3. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

  4. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

    Liver International, Vol. 35, Núm. 1, pp. 90-100

  5. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

    Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480

2013

  1. Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice

    Annals of Hepatology, Vol. 12, Núm. 2, pp. 205-212

2010

  1. Biochemical determination of lipid content in hepatic steatosis by the Soxtec method

    World Journal of Gastroenterology, Vol. 16, Núm. 12, pp. 1495-1499

  2. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  3. Niveles plasmóticos de la vitamina B12 y ácido fólicoenpacientes con hepatopatía crónica

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 4, pp. 280-287

2008

  1. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

    World Journal of Gastroenterology, Vol. 14, Núm. 10, pp. 1521-1527

  2. Resveratrol inhibits nonalcoholic fatty liver disease in rats

    BMC Gastroenterology, Vol. 8

2007

  1. Levofloxacin-induced acute hepatitis

    Journal of Bronchology

  2. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer

    Gut, Vol. 56, Núm. 12, pp. 1714-1718

  3. Selective sphincteroplasty of the papilla in cases at risk due to atypical anatomy

    World Journal of Gastroenterology, Vol. 13, Núm. 22, pp. 3106-3111

2006

  1. Consume moderado de alcohol y mortalidad por diversas causas

    Atencion Primaria

  2. Effect of resveratrol on alcohol-induced mortality and liver lesions in mice

    BMC Gastroenterology, Vol. 6